Provention Plans Two-Phase Launch Of Tzield, Pricing Drug Higher Than Expected

 
• By Alaric DeArment
Provention won FDA approval for Tzield, its drug to delay onset of stage 3 type 1 diabetes • Source: Shutterstock

More from New Products

More from Scrip